| URL: | http://www.redo-project.org/cancer-drugs-db |
| Full name: | |
| Description: | CancerDrugs_DB is a curated listing of licensed cancer drugs produced by the Anticancer Fund. Source data comes from the NCI, FDA, EMA and other data sources. The intention is to provide researchers, clinicians and regulators with an easily filtered database of licensed drugs used in the treatment of cancer. Drugs which are used in cancer treatments to alleviate symptoms or other supportive care uses or which are used for diagnostic purposes are not included. Investigational agents and experimental treatments being used in clinical trials are also not included. |
| Year founded: | 2021 |
| Last update: | |
| Version: | |
| Accessibility: |
Accessible
|
| Country/Region: | Belgium |
| Data type: | |
| Data object: | |
| Database category: | |
| Major species: | |
| Keywords: |
| University/Institution: | Anticancer Fund |
| Address: | |
| City: | |
| Province/State: | |
| Country/Region: | Belgium |
| Contact name (PI/Team): | Pan Pantziarka |
| Contact email (PI/Helpdesk): | anticancer.org.uk@gmail.com |
|
An Open Access Database of Licensed Cancer Drugs. [PMID: 33776770]
A global, comprehensive and open access listing of approved anticancer drugs does not currently exist. Partial information is available from multiple sources, including regulatory authorities, national formularies and scientific agencies. Many such data sources include drugs used in oncology for supportive care, diagnostic or other non-antineoplastic uses. We describe a methodology to combine and cleanse relevant data from multiple sources to produce an open access database of drugs licensed specifically for therapeutic antineoplastic purposes. The resulting list is provided as an open access database, (http://www.redo-project.org/cancer-drugs-db/), so that it may be used by researchers as input for further research projects, for example literature-based text mining for drug repurposing. |